|
Index of reports
> Cases with Cardio-Respiratory Arrest ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include cardio-respiratory arrest. The selected reports were submitted to the FDA during the sample period of about a year.
Possible PEG-Intron side effects in 62 year old male
Reported by a physician from Japan on 2012-02-10
Patient: 62 year old male, weighing 76.0 kg (167.2 pounds)
Reactions: Brain Death, Confusional State, Prostatitis, Pulmonary Embolism, Pyrexia, Cardio-Respiratory Arrest, Malaise, Chest Pain, Pulmonary Artery Thrombosis, Decreased Appetite, Persecutory Delusion, Rash, Delirium, Aggression, Haemoglobin Decreased, Hypoxic-Ischaemic Encephalopathy, Visual Impairment, Venous Thrombosis, Blood Pressure Decreased, Cardiac Arrest, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MP-424 (Investigational Drug)
Dosage: 2250 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2009-02-03
End date: 2009-04-17
Ribavirin
Dosage: 800 mg;qd;po 600 mg;qd;po 400 mg;qd;po 200 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2009-04-20
End date: 2009-04-25
Ribavirin
Dosage: 800 mg;qd;po 600 mg;qd;po 400 mg;qd;po 200 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2009-02-13
End date: 2009-04-19
Ribavirin
Dosage: 800 mg;qd;po 600 mg;qd;po 400 mg;qd;po 200 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2009-02-03
End date: 2009-02-23
Ribavirin
Dosage: 800 mg;qd;po 600 mg;qd;po 400 mg;qd;po 200 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2009-02-24
End date: 2009-03-09
PEG-Intron
Dosage: 120 mcg;qw;sc
Indication: Hepatitis C
Start date: 2009-02-03
End date: 2009-04-22
Other drugs received by patient: Cefotiam Hydrochloride; Imipenem and Cilastatin Sodium; Lendormin D; Loxonin; Levofloxacin; Selbex; Harnal D; Cernilton (Cernitin Pollen Extract); Soldem 3A
|
